Build-a-Cell
a US-led network (including the Kate Adamala lab at the University of Minnesota) coordinates bottom-up artificial-cell research and open standards for vesicle bioengineering.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsepaefsanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Minimal genomes & synthetic cells | genome-engineering | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.